Terence A. (Terry) Walts, MBA

Terence A. (Terry) Walts, MBA

INTERIM CEO, DIRECTOR

Terry currently serves as President, CEO of Cambium Medical Technologies LLC, a start-up out of Emory University developing proprietary platelet-derived biologics for certain therapeutic applications including chronic dry eye.  Additionally, he currently serves as consultant and Director of Cambium Oncology LLC, a company he helped found in early 2018. From 2006-16 he served as President and CEO of 3Ti, LLC, a medical device/diagnostics start-up developing next generation automated blood analyzer technology for the pre-transfusion diagnostics market.  From 2002-05 Mr. Walts served as President, CEO of Refocus Group (RSCS/OTB), an eye care company developing a surgical procedure for presbyopia and glaucoma, taking the company public in 2003. Before Refocus, Mr. Walts served from 1988-98 as SVP, Sales and Marketing and later SVP, New Business Development at CIBA Vision/Novartis (NVS/NYSE).  From 1995-98 he also served as Chief Marketing Officer and Director of Autonomous Technologies (NASDAQ/ATCI) a refractive laser surgical company helping take Autonomous public in 1996. Mr. Walts also served from 2005-16 as outside Director and Chair of the Board’s Compensation Committee of VirtualScopics (VSCP/NASDAQ), a medical software imaging services company for big Pharma.  During his 30+ years in life sciences he has personally taken two companies public, had three start-ups acquired by industry leaders or a strategic investor and finally-raised or help raise over ~$65 million in private start-up funding. From 1971-88 Mr. Walts pursued a career in consumer- packaged goods marketing/product management with Lever Brothers (Unilever), General Foods, Hanes Corporation, CIBA-Geigy’s Ag Division and No Nonsense (Kaiser-Roth) where he last served as VP-Marketing.    Mr. Walts holds a BS in Marketing from Indiana University and MBA (cum laude) from the University of Notre Dame.